Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

P. Cojutti · SciRah

Researcher profile · Semantic Scholar

P. Cojutti

Share profile

P. Cojutti — researcher profile on SciRah

h-index: 29
Works: 113
Citations: 2,683

Most-cited papers

Reappraisal of Linezolid Dosing in Renal Impairment To Improve Safety
R. Crass, P. Cojutti, M. Pai, F. Pea
2019Antimicrobial Agents and Chemotherapy103 citations Open access
Semantic Scholar
A 10‐Year Experience of Therapeutic Drug Monitoring (TDM) of Linezolid in a Hospital‐wide Population of Patients Receiving Conventional Dosing: Is there Enough Evidence for Suggesting TDM in the Majority of Patients?
F. Pea, P. Cojutti, M. Baraldo
2017Basic & Clinical Pharmacology & Toxicology87 citations Open access
Semantic Scholar
Impact of attaining aggressive vs. conservative PK/PD target on the clinical efficacy of beta-lactams for the treatment of Gram-negative infections in the critically ill patients: a systematic review and meta-analysis
M. Gatti, P. Cojutti, F. Pea
2024Critical Care77 citations Open access
Semantic Scholar
Expert clinical pharmacological advice may make an antimicrobial TDM program for emerging candidates more clinically useful in tailoring therapy of critically ill patients
M. Gatti, P. Cojutti, M. Bartoletti, T. Tonetti +9 more
2022Critical Care70 citations Open access
Semantic Scholar
A descriptive case series of PK/PD target attainment and microbiological outcome in critically ill patients with documented severe XDR Acinetobacter baumannii BSI and/or VAP treated with cefiderocol.
M. Gatti, M. Bartoletti, P. Cojutti, P. Gaibani +4 more
2021Journal of Global Antimicrobial Resistance66 citations Open access
Semantic Scholar
Assessment of a PK/PD Target of Continuous Infusion Beta-Lactams Useful for Preventing Microbiological Failure and/or Resistance Development in Critically Ill Patients Affected by Documented Gram-Negative Infections
M. Gatti, P. Cojutti, R. Pascale, T. Tonetti +6 more
2021Antibiotics64 citations Open access
Semantic Scholar
Might real-time pharmacokinetic/pharmacodynamic optimisation of high-dose continuous-infusion meropenem improve clinical cure in infections caused by KPC-producing Klebsiella pneumoniae?
F. Pea, P. Della Siega, P. Cojutti, A. Sartor +3 more
2017International Journal of Antimicrobial Agents64 citations
Semantic Scholar
Pharmacodynamics of teicoplanin against MRSA
V. Ramos-Martín, A. Johnson, L. McEntee, N. Farrington +5 more
2017Journal of Antimicrobial Chemotherapy56 citations
Semantic Scholar
Population Pharmacokinetics of Dalbavancin and Dosing Consideration for Optimal Treatment of Adult Patients with Staphylococcal Osteoarticular Infections
P. Cojutti, M. Rinaldi, E. Zamparini, N. Rossi +4 more
2021Antimicrobial Agents and Chemotherapy55 citations Open access
Semantic Scholar
Population Pharmacokinetics of High-Dose Continuous-Infusion Meropenem and Considerations for Use in the Treatment of Infections Due to KPC-Producing Klebsiella pneumoniae
P. Cojutti, A. Sartor, E. Righi, C. Scarparo +2 more
2017Antimicrobial Agents and Chemotherapy49 citations Open access
Semantic Scholar
Proactive therapeutic drug monitoring (TDM) may be helpful in managing long-term treatment with linezolid safely: findings from a monocentric, prospective, open-label, interventional study.
P. Cojutti, M. Merelli, M. Bassetti, F. Pea
2019Journal of Antimicrobial Chemotherapy48 citations
Semantic Scholar
Population Pharmacokinetic and Pharmacodynamic Analysis of Dalbavancin for Long-Term Treatment of Subacute and/or Chronic Infectious Diseases: The Major Role of Therapeutic Drug Monitoring
P. Cojutti, S. Tedeschi, M. Gatti, E. Zamparini +12 more
2022Antibiotics45 citations Open access
Semantic Scholar
Variability of Voriconazole Trough Levels in Haematological Patients: Influence of Comedications with cytochrome P450(CYP) Inhibitors and/or with CYP Inhibitors plus CYP Inducers
P. Cojutti, A. Candoni, F. Forghieri, M. Isola +5 more
2016Basic & Clinical Pharmacology & Toxicology44 citations Open access
Semantic Scholar
Usefulness of therapeutic drug monitoring in estimating the duration of dalbavancin optimal target attainment in staphylococcal osteoarticular infections. A proof-of-concept.
P. Cojutti, M. Rinaldi, M. Gatti, S. Tedeschi +2 more
2021International Journal of Antimicrobial Agents43 citations
Semantic Scholar
Pharmacokinetic/pharmacodynamic evaluation of linezolid in hospitalized paediatric patients: a step toward dose optimization by means of therapeutic drug monitoring and Monte Carlo simulation.
P. Cojutti, N. Maximova, G. Crichiutti, M. Isola +1 more
2015Journal of Antimicrobial Chemotherapy42 citations
Semantic Scholar
Levofloxacin Dosing Regimen in Severely Morbidly Obese Patients (BMI ≥40 kg/m2) Should Be Guided by Creatinine Clearance Estimates Based on Ideal Body Weight and Optimized by Therapeutic Drug Monitoring
M. Pai, P. Cojutti, F. Pea
2014Clinical Pharmacokinetics38 citations
Semantic Scholar
Population Pharmacokinetics and Dosing Considerations for the Use of Linezolid in Overweight and Obese Adult Patients
P. Cojutti, M. Pai, F. Pea
2018Clinical Pharmacokinetics37 citations Open access
Semantic Scholar
Stability of Generic Meropenem Solutions for Administration by Continuous Infusion at Normal and Elevated Temperatures
L. Franceschi, P. Cojutti, M. Baraldo, F. Pea
2014Therapeutic Drug Monitoring37 citations
Semantic Scholar
Real-time TDM-based optimization of continuous-infusion meropenem for improving treatment outcome of febrile neutropenia in oncohaematological patients: results from a prospective, monocentric, interventional study
P. Cojutti, D. Lazzarotto, A. Candoni, Maria Vittoria Dubbini +3 more
2020Journal of Antimicrobial Chemotherapy34 citations Open access
Semantic Scholar
Polytherapy and the risk of potentially inappropriate prescriptions (PIPs) among elderly and very elderly patients in three different settings (hospital, community, long‐term care facilities) of the Friuli Venezia Giulia region, Italy: are the very elderly at higher risk of PIPs?
P. Cojutti, L. Arnoldo, G. Cattani, S. Brusaferro +1 more
2016Pharmacoepidemiology and Drug Safety34 citations
Semantic Scholar
Pharmacokinetics and Pharmacodynamics of Continuous Infusion Meropenem in Overweight, Obese, and Morbidly Obese Patients with Stable and Unstable Kidney Function: A Step Toward Dose Optimization for the Treatment of Severe Gram-Negative Bacterial Infections
M. Pai, P. Cojutti, F. Pea
2015Clinical Pharmacokinetics34 citations Open access
Semantic Scholar
Population pharmacokinetics and dosing considerations for the use of daptomycin in adult patients with haematological malignancies
P. Cojutti, A. Candoni, V. Ramos-Martín, D. Lazzarotto +4 more
2017Journal of Antimicrobial Chemotherapy33 citations Open access
Semantic Scholar
Population Pharmacokinetics and Pharmacodynamics of Levofloxacin in Acutely Hospitalized Older Patients with Various Degrees of Renal Function
P. Cojutti, V. Ramos-Martín, I. Schiavon, Paolo Rossi +3 more
2016Antimicrobial Agents and Chemotherapy33 citations Open access
Semantic Scholar
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime/avibactam in a case series of renal critically ill patients treated for documented carbapenem-resistant Gram-negative bloodstream infections and/or ventilator-associated pneumonia.
M. Gatti, R. Pascale, P. Cojutti, M. Rinaldi +6 more
2022International Journal of Antimicrobial Agents31 citations Open access
Semantic Scholar
Co‐administration of proton pump inhibitors and/or of steroids may be a risk factor for low trough concentrations of posaconazole delayed‐released tablets in adult patients with haematological malignancies
P. Cojutti, A. Candoni, D. Lazzarotto, Nicholas Rabassi +3 more
2018British Journal of Clinical Pharmacology31 citations Open access
Semantic Scholar
Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin-6
P. Cojutti, A. Londero, P. Della Siega, Filippo Givone +4 more
2020Clinical Pharmacokinetics29 citations Open access
Semantic Scholar
A 1 year retrospective audit of quality indicators of clinical pharmacological advice for personalized linezolid dosing: one stone for two birds?
F. Pea, P. Cojutti, L. Dose, M. Baraldo
2016British Journal of Clinical Pharmacology27 citations Open access
Semantic Scholar
The knowledge and attitudes of pharmacists related to the use of dietary supplements: An observational study in northeastern Italy
L. Brunelli, L. Arnoldo, Giada Mazzilis, M. d'Angelo +3 more
2022Preventive medicine reports26 citations Open access
Semantic Scholar
Intra-abdominal penetration and pharmacodynamic exposure to fluconazole in three liver transplant patients with deep-seated candidiasis.
F. Pea, E. Righi, P. Cojutti, A. Carnelutti +3 more
2014Journal of Antimicrobial Chemotherapy26 citations Open access
Semantic Scholar
Real-Time Optimization of Pharmacodynamic Target Attainment at Infection Site during Treatment of Post-Neurosurgical Ventriculitis Caused by Carbapenem-Resistant Gram Negatives with Ceftazidime–Avibactam-Based Regimens: A Report of Two Cases
M. Gatti, G. Virgili, P. Cojutti, P. Gaibani +4 more
2022Microorganisms25 citations Open access
Semantic Scholar
Population Pharmacokinetics and Pharmacodynamic Target Attainment of Isavuconazole against Aspergillus fumigatus and Aspergillus flavus in Adult Patients with Invasive Fungal Diseases: Should Therapeutic Drug Monitoring for Isavuconazole Be Considered as Mandatory as for the Other Mold-Active Azoles
P. Cojutti, A. Carnelutti, D. Lazzarotto, E. Sozio +4 more
2021Pharmaceutics25 citations Open access
Semantic Scholar
Does Critical Illness Change Levofloxacin Pharmacokinetics?
J. Roberts, M. Cotta, P. Cojutti, M. Lugano +2 more
2015Antimicrobial Agents and Chemotherapy25 citations Open access
Semantic Scholar
Impact of a newly established expert clinical pharmacological advice program based on TDM results in tailoring antimicrobial therapies hospital-wide in a tertiary university hospital: findings after the first-year of implementation.
P. Cojutti, M. Gatti, F. Bonifazi, F. Caramelli +18 more
2023International Journal of Antimicrobial Agents24 citations Open access
Semantic Scholar
Clinical and pharmacokinetic drug evaluation of delafloxacin for the treatment of acute bacterial skin and skin structure infections
M. Bassetti, D. Pecori, P. Cojutti, E. Righi +1 more
2017Expert Opinion on Drug Metabolism & Toxicology24 citations
Semantic Scholar
A descriptive case series of the relationship between maintenance over time of conservative PK/PD efficacy thresholds of dalbavancin and clinical outcome in long-term treatment of staphylococcal osteoarticular infections.
M. Gatti, P. Viale, P. Cojutti, E. Zamparini +4 more
2023International Journal of Antimicrobial Agents22 citations Open access
Semantic Scholar
Impact of Maximizing Css/MIC Ratio on Efficacy of Continuous Infusion Meropenem Against Documented Gram-Negative Infections in Critically Ill Patients and Population Pharmacokinetic/Pharmacodynamic Analysis to Support Treatment Optimization
P. Cojutti, M. Gatti, M. Rinaldi, T. Tonetti +6 more
2021Frontiers in Pharmacology21 citations Open access
Semantic Scholar
Population pharmacokinetics of continuous-infusion ceftazidime in febrile neutropenic children undergoing HSCT: implications for target attainment for empirical treatment against Pseudomonas aeruginosa.
P. Cojutti, N. Maximova, G. Schillani, W. Hope +1 more
2019Journal of Antimicrobial Chemotherapy19 citations Open access
Semantic Scholar
Might isoniazid plasma exposure be a valuable predictor of drug-related hepatotoxicity risk among adult patients with TB?
P. Cojutti, Silvia Duranti, M. Isola, M. Baraldo +3 more
2016Journal of Antimicrobial Chemotherapy19 citations
Semantic Scholar
Piperacillin-tazobactam vs. carbapenems for treating hospitalized patients with ESBL-producing Enterobacterales bloodstream infections: a systematic review and meta-analysis.
M. Gatti, P. Cojutti, F. Pea
2024Journal of Global Antimicrobial Resistance17 citations Open access
Semantic Scholar
Population pharmacokinetics of continuous infusion piperacillin/tazobactam in very elderly hospitalized patients and considerations for target attainment against Enterobacterales and Pseudomonas aeruginosa.
P. Cojutti, E. Morandin, M. Baraldo, F. Pea
2021International Journal of Antimicrobial Agents17 citations
Semantic Scholar
Valganciclovir Pharmacokinetics in Patients Receiving Oral Prophylaxis Following Kidney Transplantation and Model-Based Predictions of Optimal Dosing Regimens
T. Tängdén, P. Cojutti, J. Roberts, F. Pea
2018Clinical Pharmacokinetics17 citations Open access
Semantic Scholar
Limited sampling strategies for determining the area under the plasma concentration-time curve for isoniazid might be a valuable approach for optimizing treatment in adult patients with tuberculosis.
P. Cojutti, M. Giangreco, M. Isola, F. Pea
2017International Journal of Antimicrobial Agents17 citations
Semantic Scholar
Pharmacokinetics and Pharmacodynamics of Continuous-Infusion Meropenem in Pediatric Hematopoietic Stem Cell Transplant Patients
P. Cojutti, N. Maximova, F. Pea
2015Antimicrobial Agents and Chemotherapy17 citations Open access
Semantic Scholar
Balancing the scales: achieving the optimal beta-lactam to beta-lactamase inhibitor ratio with continuous infusion piperacillin/tazobactam against extended spectrum beta-lactamase producing Enterobacterales
P. Cojutti, M. Pai, T. Tonetti, A. Siniscalchi +2 more
2024Antimicrobial Agents and Chemotherapy16 citations Open access
Semantic Scholar
Fast and Sensitive Analysis of Cefiderocol in Human Plasma Microsamples by Liquid Chromatography-Isotope Dilution Tandem Mass Spectrometry for Therapeutic Drug Monitoring
R. Barone, M. Conti, P. Cojutti, M. Gatti +2 more
2023Antibiotics16 citations Open access
Semantic Scholar
Implementation and validation of a Bayesian method for accurately forecasting duration of optimal pharmacodynamic target attainment with dalbavancin during long-term use for treating subacute and/or chronic staphylococcal infections.
P. Cojutti, M. Gatti, N. Punt, Jiři Douša +4 more
2023International Journal of Antimicrobial Agents15 citations Open access
Semantic Scholar
Population Pharmacokinetics and Monte Carlo Simulation for Dosage Optimization of Fosfomycin in the Treatment of Osteoarticular Infections in Patients without Renal Dysfunction
M. Rinaldi, P. Cojutti, E. Zamparini, S. Tedeschi +5 more
2021Antimicrobial Agents and Chemotherapy15 citations Open access
Semantic Scholar
Treatment of Candida infections with fluconazole in adult liver transplant recipients: Is TDM‐guided dosing adaptation helpful?
E. Righi, A. Carnelutti, U. Baccarani, A. Sartor +3 more
2019Transplant Infectious Disease15 citations Open access
Semantic Scholar
Monitoring Polypharmacy in Healthcare Systems Through a Multi-Setting Survey: Should We Put More Attention on Long Term Care Facilities?
L. Arnoldo, G. Cattani, P. Cojutti, F. Pea +1 more
2016Journal of Public Health Research15 citations Open access
Semantic Scholar
Daptomycin underexposure in a young intravenous drug user who was affected by life-threatening Staphylococcus aureus-complicated skin and soft tissue infection associated with bacteraemia
F. Pea, Massimo Crapis, P. Cojutti, Matteo Bassetti
2014Infection15 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

F. Pea×49
Invite
F. Pea — researcher profile on SciRah
M. Gatti×14
Invite
M. Gatti — researcher profile on SciRah
P. Viale×12
Invite
P. Viale — researcher profile on SciRah
M. Giannella×7
Invite
M. Giannella — researcher profile on SciRah

×7

Invite

M. Bassetti — researcher profile on SciRah

Invite

S. Tedeschi — researcher profile on SciRah

Invite

M. Baraldo — researcher profile on SciRah

Invite

M. Conti — researcher profile on SciRah

Invite

M. Pai — researcher profile on SciRah

Invite

T. Tonetti — researcher profile on SciRah

Invite

W. Hope — researcher profile on SciRah

Invite

M. Rinaldi — researcher profile on SciRah